The structure of human CD23 and its interactions with IgE and CD21

The low-affinity immunoglobulin E (IgE) receptor, CD23 (FcɛRII), binds both IgE and CD21 and, through these interactions, regulates the synthesis of IgE, the antibody isotype that mediates the allergic response. We have determined the three-dimensional structure of the C-type lectin domain of CD23 in solution by nuclear magnetic resonance spectroscopy. An analysis of concentration-dependent chemical shift perturbations have allowed us to identify the residues engaged in self-association to the trimeric state, whereas ligand-induced changes have defined the binding sites for IgE and CD21. The results further reveal that CD23 can bind both ligands simultaneously. Despite the C-type lectin domain structure, none of the interactions require calcium. We also find that IgE and CD23 can interact to form high molecular mass multimeric complexes. The interactions that we have described provide a solution to the paradox that CD23 is involved in both up- and down-regulation of IgE and provide a structural basis for the development of inhibitors of allergic disease.

[1]  David Fear,et al.  The biology of IGE and the basis of allergic disease. , 2001, Annual review of immunology.

[2]  J. Trowsdale,et al.  Cutting Edge: DC-SIGN; a Related Gene, DC-SIGNR; and CD23 Form a Cluster on 19p131 2 , 2000, The Journal of Immunology.

[3]  G. Delespesse,et al.  Mechanisms of formation of IgE-binding factors (soluble CD23)--I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights. , 1989, Molecular immunology.

[4]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[5]  R. Andrew Byrd,et al.  ASSOCIATION OF BIOMOLECULAR SYSTEMS VIA PULSED FIELD GRADIENT NMR SELF-DIFFUSION MEASUREMENTS , 1995 .

[6]  J. Banchereau,et al.  Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. , 1991, Journal of immunology.

[7]  R. Owens,et al.  The crystal structure of IgE Fc reveals an asymmetrically bent conformation , 2002, Nature Immunology.

[8]  R. Riek,et al.  Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Saxon,et al.  Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. , 1989, Journal of immunology.

[10]  D. Cowburn,et al.  The structure of the IgE Cepsilon2 domain and its role in stabilizing the complex with its high-affinity receptor FcepsilonRIalpha. , 2001, Nature structural biology.

[11]  R. Ghirlando,et al.  Conformation of the isolated cepsilon3 domain of IgE and its complex with the high-affinity receptor, FcepsilonRI. , 2000, Biochemistry.

[12]  D. Conrad,et al.  IgE regulation in CD23 knockout and transgenic mice. , 1999, Allergy.

[13]  H. Dyson,et al.  Coupling of folding and binding for unstructured proteins. , 2002, Current opinion in structural biology.

[14]  K. D. Zylan,et al.  Article , 1996, Physiology & Behavior.

[15]  D. Fushman,et al.  Efficient and accurate determination of the overall rotational diffusion tensor of a molecule from (15)N relaxation data using computer program ROTDIF. , 2004, Journal of magnetic resonance.

[16]  Padlan Ea,et al.  Modeling of the lectin-homology domains of the human and murine low-affinity Fc epsilon receptor (Fc epsilon RII/CD23). , 1993 .

[17]  Z. Eshhar,et al.  Fine specificity of the IgE interaction with the low and high affinity Fc receptor. , 1993, Journal of immunology.

[18]  A. Bax,et al.  Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.

[19]  T. Jardetzky,et al.  Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains , 2000 .

[20]  E. Padlan,et al.  The B-cell binding site on human immunoglobulin E , 1988, Nature.

[21]  J. Bonnefoy,et al.  Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes , 1992, The Journal of experimental medicine.

[22]  D. Fearon,et al.  Complement: instructing the acquired immune system through the CD21/CD19 complex. , 1996, Research in immunology.

[23]  R. Owens,et al.  Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosylation site mutants. , 1995, Protein engineering.

[24]  P. V. van Zijl,et al.  Water exchange filter with improved sensitivity (WEX II) to study solvent-exchangeable protons. Application to the consensus zinc finger peptide CP-1. , 1996, Journal of magnetic resonance. Series B.

[25]  J. Gready,et al.  Comparative analysis of structural properties of the C‐type‐lectin‐like domain (CTLD) , 2003, Proteins.

[26]  J. Bonnefoy,et al.  CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.

[27]  R. Reljic,et al.  Function of CD23 in the response of human B cells to antigen , 1997, European journal of immunology.

[28]  E. Padlan,et al.  Modeling of the lectin-homology domains of the human and murine low-affinity Fc epsilon receptor (Fc epsilon RII/CD23). , 1993, Receptor.

[29]  D. Katz,et al.  The binding of IgE to murine Fc epsilon RII is calcium-dependent but not inhibited by carbohydrate. , 1990, Journal of immunology.

[30]  Giovanni Lipari,et al.  MODEL-FREE APPROACH TO THE INTERPRETATION OF NUCLEAR MAGNETIC RESONANCE RELAXATION IN MACROMOLECULES. 1. THEORY AND RANGE OF VALIDITY , 1982 .

[31]  D. Myszka,et al.  Improving biosensor analysis , 1999, Journal of molecular recognition : JMR.

[32]  B. Cheson,et al.  Novel therapies for chronic lymphocytic leukemia. , 2004, Blood reviews.

[33]  R. Owens,et al.  Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E. , 1997, Biochemistry.

[34]  H. Sewell,et al.  Cleavage of the low‐affinity receptor for human IgE (CD23) by a mite cysteine protease: Nature of the cleaved fragment in relation to the structure and function of CD23 , 1997, European journal of immunology.

[35]  Maureen E. Taylor,et al.  Structure-function analysis of C-type animal lectins. , 2003, Methods in enzymology.

[36]  C. Isacke,et al.  Characterization of Sugar Binding by the Mannose Receptor Family Member, Endo180* , 2002, The Journal of Biological Chemistry.

[37]  T. Honjo,et al.  Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Korsmeyer,et al.  Solution Structure of the Proapoptotic Molecule BID A Structural Basis for Apoptotic Agonists and Antagonists , 1999, Cell.

[39]  D. Conrad,et al.  The oligomeric nature of the murine Fc epsilon RII/CD23. Implications for function. , 1993, Journal of immunology.

[40]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[41]  D. Fearon,et al.  CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. , 1992, Science.

[42]  V. Holers,et al.  CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. , 1994, Journal of immunology.

[43]  J. Bonnefoy,et al.  Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo , 1995, Nature Medicine.

[44]  J. Bonnefoy,et al.  CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution. , 1995, Immunology.

[45]  V. Michael Holers,et al.  Structure of Complement Receptor 2 in Complex with Its C3d Ligand , 2001, Science.

[46]  R. Owens,et al.  Interaction of the Low-Affinity Receptor CD23/FcεRII Lectin Domain with the Fcε3−4 Fragment of Human Immunoglobulin E† , 1997 .

[47]  M. Taylor,et al.  Active papain renatured and processed from insoluble recombinant propapain expressed in Escherichia coli. , 1992, Protein engineering.

[48]  Peter G Schultz,et al.  Structural plasticity and the evolution of antibody affinity and specificity. , 2003, Journal of molecular biology.

[49]  David Cowburn,et al.  The structure of the IgE Cɛ2 domain and its role in stabilizing the complex with its high-affinity receptor FcɛRIα , 2001, Nature Structural Biology.

[50]  W. Busse,et al.  Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. , 2003, The Journal of allergy and clinical immunology.

[51]  F. Finkelman,et al.  Induction of B cell apoptosis by co-cross-linking CD23 and sIg involves aberrant regulation of c-myc and is inhibited by bcl-2. , 1997, International immunology.

[52]  P. Debré,et al.  Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. , 1992, The EMBO journal.